2022 In Vitro Diagnostics (IVD) Market in Malaysia, Singapore and Indonesia: Featuring Caris Life Sciences, Cephei, CTK Biotech, Danaher and Dexcom Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022” has been added ResearchAndMarkets.com’s sacrifice

The Asia Pacific (APAC) region is a rapidly growing in vitro diagnostics (IVD) market, which is witnessing increasing focus from leading global players in the market. Southeast Asia has been identified as one of the key regions in the APAC region that offers significant opportunities for IVD companies.

This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia and Singapore. These three countries together represent a fast-growing geographic region that offers significant opportunities for IVD companies. The total population of these three countries is over 310 million, which is close to the population of the United States.

Among these three countries, Singapore has established world-class health service capabilities in terms of infrastructure as well as skilled manpower. Although the population is less than 6 million, the Singapore market is attractive to IVD companies and it has become a medical tourism hub in the region.

Indonesia, on the other hand, is a country with a huge population of around 275 million people. The country is making significant strides to improve its healthcare infrastructure, which offers significant opportunities for IVD companies. The Malaysian market, with a population of around 32 million falls between these two countries, both in terms of health service capabilities and growth potentials.

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:

  • POC

  • Clinical chemistry

  • Immunoassays

  • Molecular assays

  • Hematology

  • Coagulation

  • Microbiology and Virology

  • Blood test and typing

  • Histology and cytology

The report also profiles key companies in the market:

  • Abbott Diagnostics


  • Beckman Coulter, Inc. / Danaher

  • Becton, Dickinson and Company (BD)

  • The shares of BioCytech Corporation

  • BioMerieux Inc.

  • The history of Bio-Rad Laboratories, Inc.

  • Caris Life Sciences

  • Cephei

  • The capitalization of CTK Biotech Inc

  • Danaher Corporation

  • Dexcom

  • DiaSorin SpA

  • Grifols SA

  • Healgen Scientific LLC

  • Hologic, Inc.

  • Horiba Medical

  • Lucence Diagnostics

  • Medical Innovation Ventures Sdn. Bhd. (mediven)

  • Mindray (Shenzhen Mindray Bio-Medical Electronics Co., Ltd.)

  • MiRXES Pte Ltd.

  • The history of OraSure Technologies, Inc.

  • Ortho Clinical Diagnostics (Ortho)

  • PerkinElmer, Inc. (PE)


  • Reszon Diagnostics International

  • Roche Diagnostics

  • Sysmex Corporation Capitalization

  • Vela diagnostics

  • Veredus Laboratories Pte Ltd

Key topics covered:

Chapter 1: Executive Summary

Chapter 2: COVID-19 Testing Market Trends

Chapter 3: Point-of-care tests

Chapter 4: Core Lab and Clinical Chemistry

Chapter 5: Immunoassays

Chapter 6: Molecular Assays

Chapter 7: Hematology

Chapter 8: Coagulation

Chapter 9: Microbiology and Virology

Chapter 10: Blood Banking Services

Chapter 11: Histology and Cytology

Chapter 12: Company Profiles

For more information on this report visit https://www.researchandmarkets.com/r/a33wbm


Also Read :  Cebu Pacific happy to offer international travel for less

Leave a Reply

Your email address will not be published.